glp-1 neuropathy receptor agonists are being prescribed to tens of millions of patients with obesity. What no one can yet answer is whether those drugs are protecting their peripheral nerves or damaging them GLP-1 Genetics: How Genes Affect
Description
Journal of Diabetes and Its Complications, 38(10), 108834

Just one capsule in the morning and one in the afternoon and done

However, drop-out rates (due to side effects, cost, or time) are substantial, especially outside trials

The expansion targets 11 states where Humana already operates, planning to add center density in existing markets

FDA news release

April 30, 2024
